8:00 |
Registration |
|
|
|
Epidemiology
chairs: Joep Lange (AMC, Amsterdam), Bert Hofman (EMC, Rotterdam)
|
9.00 |
cART and the HIV epidemic in the Netherlands |
Frank de Wolf (SHM, Amsterdam) |
9:20 |
Set-point viral load and transmissibility |
Christophe Fraser (Imperial College, London) |
9:45 |
Transmission networks of (resistant) HIV-1 among MSM in the Netherlands |
Daniela Bezemer (SHM, Amsterdam) |
9:55 |
High prevalence of asymptomatic STI in HIV-positive MSM, visiting HIV-outpatient clinics in the Netherlands |
Marlies Heiligenberg (GGD, Amsterdam) |
|
|
|
10:05 |
Coffee break |
|
|
|
|
Prevention
chairs: Ton Coenen (AIDS Fonds, Amsterdam), Maria Prins (GGD, Amsterdam)
|
10:45 |
The role of male circumcision in preventing HIV transmission |
Janneke van de Wijgert (AMC, Amsterdam) |
11:05 |
Are AIDS vaccines uniquely difficult to develop? The key role of correlates of protection |
Jaap Goudsmit (Crucell, Leiden) |
11:35 |
In patients on cART without an undetectable viral load measured in the last three months the use of condoms is crucial to reduce HIV transmission |
Colette Smit (SHM, Amsterdam) |
11:45 |
Personalized stigma and disclosure concerns among HIV infected indigenous and non-indigenous patients |
Pythia Nieuwkerk (AMC, Amsterdam) |
|
|
|
12:00 |
Lunch and poster viewing |
|
|
|
|
Pathogenesis
chairs: Hanneke Schuitemaker (AMC, Amsterdam), Frank Miedema (UMCU, Utrecht)
|
13:30 |
STD’s increase HIV susceptibility by altering Langerhans cell function |
Theo Geijtenbeek (AMC, Amsterdam) |
13:50 |
Adaptation of HIV to the HLA background of its host |
José Borghans (UMCU, Utrecht) |
14:15 |
Acute HIV-1 Infection: Alterations in Lymphoid and Myeloid Cell Numbers and Infection Levels |
Georgios Pollakis (AMC, Amsterdam) |
14:25 |
Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level |
Evelien Bunnik (AMC, Amsterdam) |
|
|
|
14:45 |
Tea break |
|
|
|
|
Treatment
chairs: Ineke van der Ende (EMC, Rotterdam), Frank Kroon (UMCL, Leiden)
|
15:15 |
HIV-infected patients with positive MT-2 cultures may need more frequent monitoring and HAART initiation at higher CD4 counts |
Angélique van ‘t Wout (AMC, Amsterdam) |
15:35 |
Abacavir and cardiovascular risk |
Peter Reiss (AMC, Amsterdam) |
16:00 |
Evaluation of safety and efficacy of anti-HIV-1 shRNA expression in vivo |
Mireille Centlivre (AMC, Amsterdam) |
16:10 |
Episodes of HIV viremia and the risk of non-AIDS events amongst successfully treated patients |
Shuangjie Zhang (SHM, Amsterdam) |
|
|
|
Keynote
chair : Roel Coutinho (RIVM, Bilthoven)
|
16:30 |
The early AIDS epidemic in the United States |
Harold Jaffe (University of Oxford) |
|
|
|
Closure
chair: Frank de Wolf (SHM, Amsterdam)
|
17:45 |
Dutch policy on HIV/Aids - the role of research |
Marijke Wijnroks (Ministry of Foreign Affairs, The Hague; Netherlands HIV/AIDS Ambassador) |
|
Drinks |
|
